CSL Behring is issuing a follow-up to the communication sent to customers on July 21, 2016 regarding a voluntary recall of two lots of hemophilia A drug Helixate FS containing active ingredient manufactured before November 2015.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/325cTgK
No comments:
Post a Comment